Posts in category Healthcare


Exclusive Interview with Namaste Technologies (NXTTF) CEO Sean Dollinger

Namaste Technologies (OTCMKTS:NXTTF) CEO and Co-Founder Sean Dollinger started his company with the dream of …

Read more

Valeant Pharmaceuticals Intl Inc (VRX): A Company in Existential Crisis

  Valeant Pharmaceuticals Intl Inc (NYSE:VRX) will be reporting earnings next month, and if Valeant’s …

Read more

Here Why You Shouldn’t Give Up on Valeant Pharmaceuticals Intl Inc (VRX) Just Yet

It is not much of a surprise that troubled pharma company Valeant Pharmaceuticals Intl Inc …

Read more

Analyzing Bill Ackman’s Stock Portfolio: Valeant Pharmaceuticals Intl Inc (VRX), Chipotle Mexican Grill, Inc. (CMG)

by Nicholas McCullum Stock screeners allow investors to filter for nearly any quantitative metric. Dividend …

Read more

Who’s Better Pharma Dividend Stock: Gilead Sciences, Inc. (GILD) or AbbVie Inc (ABBV)?

by Bob Ciura Pharmaceutical companies are among the strongest dividend growth stocks in the market. …

Read more

Valeant Pharmaceuticals Intl Inc (VRX) Legal Mess Is An Existential Threat

As if declining EBITDA, political pressure, and debt were not bad enough, Valeant Pharmaceuticals Intl …

Read more

What Can Valeant Pharmaceuticals Intl Inc (VRX) Do to Get out of This Mess?

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) continues its freefall, breaking below $10 for the first time …

Read more

Valeant Pharmaceuticals Intl Inc (VRX): Weak Growth Drivers, No Room for R&D

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) turnaround story depends on transforming from an acquisition-based ‘platform’ company …

Read more

Is Investing in Valeant Pharmaceuticals Intl Inc (VRX) a Mistake?

It’s fair to say that Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is struggling to keep its …

Read more

How Should Investors Value Valeant Pharmaceuticals Intl Inc (VRX)?

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock has lost over 25% in 2017 alone. Yet, is the …

Read more